Anupam Rasayan India Ltd

Anupam Rasayan India Debt & Borrowing

Anupam Rasayan India Limited has allotted non-convertible debt securities. The company filed this disclosure in accordance with SEBI LODR requirements.

Anupam Rasayan India Debt & Borrowing: ₹145 Cr

Anupam Rasayan India Ltd allotted 14,500 non-convertible debentures aggregating ₹145 Crore on a private placement basis. The proceeds will be used for debt repayment and corporate purposes.

Value

₹145.0 Cr

Anupam Rasayan India Debt & Borrowing: ₹160 Cr

Anupam Rasayan India Ltd. approved the private placement issuance of 16,000 non-convertible debentures (NCDs) aggregating to ₹160 Crore to Aditya Birla Capital Limited.

Value

₹160.0 Cr

From

Aditya Birla Capital Limited

Execution

13 months

Anupam Rasayan India Debt & Borrowing: ₹300 Cr

Anupam Rasayan approved a corporate guarantee of up to ₹300 Crore and a share pledge for financing availed by its subsidiary, Mates Visa Consultancy.

Value

₹300.0 Cr

Anupam Rasayan India Board Meeting Date

Anupam Rasayan India Ltd has scheduled a board meeting for September 19, 2026, to discuss potential fund-raising via a debt issue.

Anupam Rasayan India Board Meeting Date

Anupam Rasayan India Ltd announced a Board Meeting on September 19, 2026, to consider raising up to ₹160 Crore via non-convertible debentures.

Value

₹160.0 Cr

Anupam Rasayan India Annual Report

Anupam Rasayan India Ltd has submitted its Integrated Annual Report for the financial year 2025-26, as required under SEBI listing regulations.

Anupam Rasayan India Annual General Meeting

Anupam Rasayan India Ltd. issued a notice for its 23rd Annual General Meeting scheduled for September 30, 2026, to conduct regular business and approve dividend.

Anupam Rasayan India Management Change

Anupam Rasayan India Limited has appointed Ms. Hetvi Vyas as Deputy Chief Financial Officer, effective September 8, 2026. This move strengthens the company's financial leadership team.

Anupam Rasayan India Acquisition Worth ₹60.88 Cr

Anupam Rasayan India Ltd. acquired 2,60,065 shares in Tanfac Industries Ltd. for ₹60.88 Crore via a preferential issue to increase its stake in the subsidiary.

Value

₹60.88 Cr

Anupam Rasayan India Board Meeting Outcome

Anupam Rasayan India Ltd has appointed Ms. Hetvi Vyas as Deputy Chief Financial Officer and Key Managerial Personnel of the Company, effective September 08, 2026.

Anupam Rasayan India Dividend

Anupam Rasayan India Ltd. has fixed September 18, 2026, as the record date for its FY 2025-26 final dividend payment.

Anupam Rasayan India Annual General Meeting

Anupam Rasayan India Ltd approved its 23rd AGM notice, appointed a new Deputy CFO, and approved the acquisition of Tanfac Industries shares for ₹60.88 Crore.

Value

₹60.88 Cr

Anupam Rasayan India Bags ₹3,415 Cr Order from A major speciality metal manufacturer

Anupam Rasayan India Limited secured a Rs. 3,415 Crore supply contract from a US-based speciality metal manufacturer. This multi-year order spans 6 years.

Value

₹3,415 Cr

From

A major speciality metal manufacturer (USA)

Execution

6 years

Anupam Rasayan India Bags New Order from Global speciality metal manufacturer

Anupam Rasayan secured a six-year specialty chemical supply contract from a US-based global major. Dispatches are expected to commence from the latter half of Q3 FY27.

From

Global speciality metal manufacturer

Execution

6 years

Anupam Rasayan India Earnings Call Transcript: Key Takeaways

Anupam Rasayan started FY27 with 36% revenue growth, primarily driven by the Jehoshaphat (J-Hock) acquisition and new product commercialization in flow chemistry.

Call

Guides 25% growth

Anupam Rasayan India Investor Presentation: Key Takeaways

Anupam Rasayan reported strong Q1FY27 consolidated revenue of ₹6,675 Mn, up 36% YoY. Strategy focuses on expanding the fluorination and CDMO platforms via strategic acquisitions of Jayhawk and Bliss GVS Pharma.

Anupam Rasayan India Q1 FY27 Results: Net Profit ₹51.2 Cr, Up 5.6% YoY

Anupam Rasayan India Ltd reported revenue from operations of ₹655 Cr (+34.8% YoY) and net profit of ₹51.2 Cr (+5.6% YoY) for Q1 FY27.

Key figure

Net profit ₹51.2 Cr · +5.6% YoY

Anupam Rasayan India Earnings Call: Key Takeaways

Q4FY25 saw 31% QoQ consolidated revenue growth. Full year FY25 consolidated revenue was ₹14,485 Mn, a 4% YoY degrowth, reflecting H1 macro weakness recovered in H2.

Anupam Rasayan India Earnings Call: Key Takeaways

Anupam Rasayan delivered record FY26 revenue of ₹2,384cr, up 65% YoY, driven by acquisitions and diversification into Pharma and Fluorination.

Anupam Rasayan India Earnings Call: Key Takeaways

Anupam Rasayan delivered record FY26 revenue of ₹2,384cr, driven by aggressive acquisitions (J-Hock, Bliss GVS) and a pivot from agrochemicals to high-margin pharma and polymer segments.

Anupam Rasayan India Earnings Call: Key Takeaways

Anupam Rasayan announced the acquisition of Bliss GVS Pharma (43.3-48.2% stake plus open offer) to expand into pharmaceutical formulations and regulated markets like the USA.

Anupam Rasayan India Earnings Call: Key Takeaways

Anupam Rasayan reported record FY26 consolidated revenue of ₹23,836 Mn (up 65% YoY) and PAT of ₹2,222 Mn (up 39% YoY). Strategy focuses on backward integration via Tanfac and US expansion through Jayhawk acquisition.

Anupam Rasayan India Q4 FY26 Results: Net Profit ₹56 Cr, Down 11.0% YoY

Anupam Rasayan India Ltd reported revenue from operations of ₹635.8 Cr (+27.1% YoY) and net profit of ₹56 Cr (-11.0% YoY) for Q4 FY26.

Key figure

Net profit ₹56 Cr · -11.0% YoY